Erasca, Inc. (ERAS)
Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim on July 1, 2018 and is headquartered in San Diego, CA.
Address
10835 ROAD TO THE CURE, SUITE 140
SAN DIEGO, CA 92121
Founded
2018
Number of Employees
126
Website
http://www.erasca.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)